Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Triamcinolone Acetonide · Kenalog-40, Nasacort

Small molecule · Agonist of glucocorticoid receptor (NR3C1) · developed by Apothecon

Approved FDA, Feb 1965
3 Registered trials

What is Triamcinolone Acetonide?

Triamcinolone acetonide is a corticosteroid that binds and activates the glucocorticoid receptor, producing anti-inflammatory and immunomodulating effects. It is studied in osteoarthritis of the knee and glenohumeral joint, and in postoperative ocular inflammation and pain.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Kenalog-40, Nasacort, Nasacort Allergy 24Hr, Nasacort Hfa, FX-006, FX-1005, FX-1006, ZILRETTA
Drug type
Small molecule
Targets
glucocorticoid receptor (NR3C1)
Mechanism
Agonist of glucocorticoid receptor (NR3C1)
Pathways
arachidonic acid release inhibition, prostaglandin and leukotriene synthesis inhibition, inflammatory transduction pathway inhibition
Therapy area
Musculoskeletal
Developer
Apothecon
In trials of
HROW, PCRX
FDA status
Approved as Kenalog-40, Nasacort, Nasacort Allergy 24Hr (February 1, 1965), NDA014901 · FDA label
UNII
8FG9H9D31J

✅ FDA-approved uses

From the indications section of the FDA label (version of Jan 14, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT07832552 Phase 3 Postoperative Ocular Inflammation Enrolling by invitation HROW
NCT06269705 Phase 3 Glenohumeral Osteoarthritis Active not recruiting PCRX
NCT02357459 Phase 3 Osteoarthritis of the Knee Completed PCRX

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Glenohumeral OsteoarthritisPostoperative Ocular InflammationPostoperative Ocular PainOsteoarthritis of the Knee

Other drugs acting on NR3C1

Sources

Updated Nov 15, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.